Price $1.27 |
Market Cap
94M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.03
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-8.3K
|
FCF
-0.1
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-44.30%
|
ROI
-
|
|
ROA
-28.70%
|
EPS Growth
8.20%
|
Current Ratio
3.6
|
Debt/Equity
13.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.15 | - | - | 81.6M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $14.35 | - | - | 5.95B | Strong Buy |
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $2.06 | - | - | 8.8M | Strong Buy |
| Aytu Bioscience Inc (AYTU) | $0.20 | - | - | 6.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
